These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36843560)

  • 81. Therapeutic Strategies for Duchenne Muscular Dystrophy: An Update.
    Sun C; Shen L; Zhang Z; Xie X
    Genes (Basel); 2020 Jul; 11(8):. PubMed ID: 32717791
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The discovery of the DNA methylation episignature for Duchenne muscular dystrophy.
    Schreyer L; Reilly J; McConkey H; Kerkhof J; Levy MA; Hu J; Hnaini M; Sadikovic B; Campbell C
    Neuromuscul Disord; 2023 Jan; 33(1):5-14. PubMed ID: 36572586
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Dystrophin-deficient pigs provide new insights into the hierarchy of physiological derangements of dystrophic muscle.
    Klymiuk N; Blutke A; Graf A; Krause S; Burkhardt K; Wuensch A; Krebs S; Kessler B; Zakhartchenko V; Kurome M; Kemter E; Nagashima H; Schoser B; Herbach N; Blum H; Wanke R; Aartsma-Rus A; Thirion C; Lochmüller H; Walter MC; Wolf E
    Hum Mol Genet; 2013 Nov; 22(21):4368-82. PubMed ID: 23784375
    [TBL] [Abstract][Full Text] [Related]  

  • 84. BETs inhibition attenuates oxidative stress and preserves muscle integrity in Duchenne muscular dystrophy.
    Segatto M; Szokoll R; Fittipaldi R; Bottino C; Nevi L; Mamchaoui K; Filippakopoulos P; Caretti G
    Nat Commun; 2020 Nov; 11(1):6108. PubMed ID: 33257646
    [TBL] [Abstract][Full Text] [Related]  

  • 85. A novel canine model for Duchenne muscular dystrophy (DMD): single nucleotide deletion in DMD gene exon 20.
    Mata López S; Hammond JJ; Rigsby MB; Balog-Alvarez CJ; Kornegay JN; Nghiem PP
    Skelet Muscle; 2018 May; 8(1):16. PubMed ID: 29843823
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Intrafamilial phenotypic heterogeneity related to a new DMD splice site variant.
    Coimbra Neto AR; de Carvalho SC; Leoni TB; Iwabe C; Silva TQAC; Coelho-Filho OR; Marques MJ; Nucci A; França MC
    Neuromuscul Disord; 2021 Aug; 31(8):788-797. PubMed ID: 34312044
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Prednisolone rescues Duchenne muscular dystrophy phenotypes in human pluripotent stem cell-derived skeletal muscle in vitro.
    Al Tanoury Z; Zimmerman JF; Rao J; Sieiro D; McNamara HM; Cherrier T; Rodríguez-delaRosa A; Hick-Colin A; Bousson F; Fugier-Schmucker C; Marchiano F; Habermann B; Chal J; Nesmith AP; Gapon S; Wagner E; Gupta VA; Bassel-Duby R; Olson EN; Cohen AE; Parker KK; Pourquié O
    Proc Natl Acad Sci U S A; 2021 Jul; 118(28):. PubMed ID: 34260377
    [TBL] [Abstract][Full Text] [Related]  

  • 88. A novel mouse model of Duchenne muscular dystrophy carrying a multi-exonic
    Wong TWY; Ahmed A; Yang G; Maino E; Steiman S; Hyatt E; Chan P; Lindsay K; Wong N; Golebiowski D; Schneider J; Delgado-Olguín P; Ivakine EA; Cohn RD
    Dis Model Mech; 2020 Sep; 13(9):. PubMed ID: 32988972
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Metabogenic and Nutriceutical Approaches to Address Energy Dysregulation and Skeletal Muscle Wasting in Duchenne Muscular Dystrophy.
    Rybalka E; Timpani CA; Stathis CG; Hayes A; Cooke MB
    Nutrients; 2015 Nov; 7(12):9734-67. PubMed ID: 26703720
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Non-Invasive Biomarkers for Duchenne Muscular Dystrophy and Carrier Detection.
    Anaya-Segura MA; García-Martínez FA; Montes-Almanza LA; Díaz BG; Avila-Ramírez G; Alvarez-Maya I; Coral-Vazquez RM; Mondragón-Terán P; Escobar-Cedillo RE; García-Calderón N; Vazquez-Cardenas NA; García S; López-Hernandez LB
    Molecules; 2015 Jun; 20(6):11154-72. PubMed ID: 26091074
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Therapeutic potential of PEGylated insulin-like growth factor I for skeletal muscle disease evaluated in two murine models of muscular dystrophy.
    Gehrig SM; van der Poel C; Hoeflich A; Naim T; Lynch GS; Metzger F
    Growth Horm IGF Res; 2012 Apr; 22(2):69-75. PubMed ID: 22424862
    [TBL] [Abstract][Full Text] [Related]  

  • 92. DMD genotype correlations from the Duchenne Registry: Endogenous exon skipping is a factor in prolonged ambulation for individuals with a defined mutation subtype.
    Wang RT; Barthelemy F; Martin AS; Douine ED; Eskin A; Lucas A; Lavigne J; Peay H; Khanlou N; Sweeney L; Cantor RM; Miceli MC; Nelson SF
    Hum Mutat; 2018 Sep; 39(9):1193-1202. PubMed ID: 29907980
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Heme Oxygenase-1 Influences Satellite Cells and Progression of Duchenne Muscular Dystrophy in Mice.
    Pietraszek-Gremplewicz K; Kozakowska M; Bronisz-Budzynska I; Ciesla M; Mucha O; Podkalicka P; Madej M; Glowniak U; Szade K; Stepniewski J; Jez M; Andrysiak K; Bukowska-Strakova K; Kaminska A; Kostera-Pruszczyk A; Jozkowicz A; Loboda A; Dulak J
    Antioxid Redox Signal; 2018 Jul; 29(2):128-148. PubMed ID: 29669436
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Human muscle gene expression responses to endurance training provide a novel perspective on Duchenne muscular dystrophy.
    Timmons JA; Larsson O; Jansson E; Fischer H; Gustafsson T; Greenhaff PL; Ridden J; Rachman J; Peyrard-Janvid M; Wahlestedt C; Sundberg CJ
    FASEB J; 2005 May; 19(7):750-60. PubMed ID: 15857889
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Mutation-independent Proteomic Signatures of Pathological Progression in Murine Models of Duchenne Muscular Dystrophy.
    van Westering TLE; Johansson HJ; Hanson B; Coenen-Stass AML; Lomonosova Y; Tanihata J; Motohashi N; Yokota T; Takeda S; Lehtiö J; Wood MJA; El Andaloussi S; Aoki Y; Roberts TC
    Mol Cell Proteomics; 2020 Dec; 19(12):2047-2068. PubMed ID: 32994316
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Dental pulp stem cells can improve muscle dysfunction in animal models of Duchenne muscular dystrophy.
    Nitahara-Kasahara Y; Kuraoka M; Guillermo PH; Hayashita-Kinoh H; Maruoka Y; Nakamura-Takahasi A; Kimura K; Takeda S; Okada T
    Stem Cell Res Ther; 2021 Jan; 12(1):78. PubMed ID: 33494794
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Quantifying disease activity in fatty-infiltrated skeletal muscle by IDEAL-CPMG in Duchenne muscular dystrophy.
    Mankodi A; Bishop CA; Auh S; Newbould RD; Fischbeck KH; Janiczek RL
    Neuromuscul Disord; 2016 Oct; 26(10):650-658. PubMed ID: 27593185
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Human dystrophin expressing chimeric (DEC) cell therapy ameliorates cardiac, respiratory, and skeletal muscle's function in Duchenne muscular dystrophy.
    Siemionow M; Langa P; Harasymczuk M; Cwykiel J; Sielewicz M; Smieszek J; Heydemann A
    Stem Cells Transl Med; 2021 Oct; 10(10):1406-1418. PubMed ID: 34291884
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Gait deviations in Duchenne muscular dystrophy-Part 2. Statistical non-parametric mapping to analyze gait deviations in children with Duchenne muscular dystrophy.
    Goudriaan M; Van den Hauwe M; Simon-Martinez C; Huenaerts C; Molenaers G; Goemans N; Desloovere K
    Gait Posture; 2018 Jun; 63():159-164. PubMed ID: 29751322
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Impact of Gut Microbiota on the Peripheral Nervous System in Physiological, Regenerative and Pathological Conditions.
    Calabrò S; Kankowski S; Cescon M; Gambarotta G; Raimondo S; Haastert-Talini K; Ronchi G
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.